New autism drug tested

[Guest guest]

(My posted comment; This sounds different from most drugs used to " treat "

autism. Most other drugs are only used to treat the outward signs of autism,

which many experts consider symptoms, such as hyper activity, aggressive

behavior and styming by masking them.  

This drug looks like it is designed to treat some of the biochemical problems

which exasperate the behaviors of many people with autism.)

 

http://www.app.com/apps/pbcs.dll/article?AID=2010101118156 

New autism drug tested at New Brunswick hospital

By TOM BALDWIN

NEW BRUNSWICK — Final testing of a new treatment for autism is taking place at

Saint 's University Hospital.

" We are targeting the symptoms of autism, " said Dr. Joan Fallon, founder of

Curemark LLC, a drug-research and development company located in Rye, N.Y. The

company is testing its new product at 13 locations nationwide.

The testing being conducted at Saint 's involves 170 youngsters, hospital

spokesman Phil Hartman said.

Fallon said the test pool covers children age 3 to 8. She said she expects

results " sometime early next year. "

For competitive reasons, she did not want to discuss specifics of the product,

called for now " CM-AT, " for " Curemark's autism treatment. "

She said the testing started about three months ago. Dr. Barbie Zimmerman-Bier

of Saint 's, who is running the study, said: " Subjects heard about it and

they got word from support groups. . . . There was a screening process to see

if they were eligible. They had to be between 3 and 8. "

Regarding how children are being tested to see if the drug works and how

frequently they are being checked, Fallon said, " We use standardized, validated

measures to look at change in their behaviors. "

Zimmerman-Bier reported said children were seen at the beginning of the study,

then at two weeks, four weeks, eight weeks and 12 weeks.

Curemark said in a prepared statement: " CM-AT, which has received fast-track

status from the FDA, is based on Curemark's research that showed enzyme

deficiencies in autistic children, resulting in an inability to digest protein.

The inability to digest protein affects the availability of amino acids, the

building blocks of chemicals essential for brain function.

The statement concluded, " If approved, CM-AT will be one of the first therapies

to address the underlying physiology of autism. "

Fallon said Saint 's was chosen because " they are a well-known center for

autism, " citing the work of Zimmerman-Bier, head of the developmental and

behavioral pediatrics program at Saint 's Healthcare System.

" We do see a lot of children, " Zimmerman-Bier said. " We don't know what the

children are getting. It is a double-blind study. "

" We have one of the most advanced testing methodologies in schools and in

hospitals, " Hartman said. " People actually relocate here to take advantage of

the services available in New Jersey. "

 

 

Man will ultimately be governed by God or by tyrants.

Make yourselves sheep and the wolves will eat you.

Beer is living proof that God loves us and wants us to be happy.

Ben lin